Biohaven Corp (BHVN) - Earnings per share growth in current year
The lack of recurring revenue makes investments in Biohaven Ltd. (BHVN) risky, as evidenced by the volatility of the annual EPS. The value of 65.60 reflects the metric's balance at the current stage. Biohaven Ltd. (BHVN) maintains an image as a creator of breakthrough migraine treatments, and its further growth relies on the success of epilepsy drug trials under strict cash flow management.
Analytical breakdowns and data insights for company Biohaven Ltd. (BHVN)
- market value and analyst target forecast:
- market capitalization indicators:
- book capitalization indicators:
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio Biohaven Ltd.|BHVN - Long-Term Debt to Equity|Short-Term Debt to Equity biohavenpharma.com|BHVN - Company Total Debt|Debt to Book Capital Biohaven Corp|BHVN - Company Long-Term Debts|Company Short-Term Indebtedness Biohaven|Interim Coverage Ratio biohavenpharma.com
- company profitability and valuation multiples indicators:
BHVN - Net Profit|Expected Profit Biohaven Ltd.|BHVN - P/E Multiple|Future Price to Earnings Multiple Biohaven Corp|BHVN - Price/Earnings to Growth Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Biohaven Corp|BHVN - Profit before payment of interest, taxes and amortization|Earnings per share for the last 12 months Biohaven|BHVN - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last 12 months biohavenpharma.com|BHVN - Earnings growth in current year|Expected net earnings per share growth next year Biohaven Ltd.
Summary company analysis:Biohaven Ltd - BHVN
This metric is calculated as the percentage deviation of current net earnings per share from the value of the same period last year, reflecting the actual dynamics of return on equity. Analyzing the annual EPS variation allows for an assessment of the organic pipeline development efficiency of Biohaven Ltd. and the impact of licensing agreements with Asian partners on the final business profitability, excluding M&A transactions.
Direct competitors
Biogen Inc (BIIB) - Earnings growth in current year|Net earnings per share growth this year NBIX|Earnings per share growth in current year RGC|Earnings growth in current year AXSM|ACAD - Earnings per share growth rate in current year|Earnings per share growth in current year Xenon XENE|VKTX: Earnings per share growth this year|SUPN: Net earnings per share growth this year|Earnings per share increase in current year CPRX (Catalyst Corp)|Denali Therapeutics (DNLI) - Earnings per share growth in current year|HRMY (harmonybiosciences.com) - Earnings per share growth in current year|Net earnings per share growth this year AMLX|TRVI (Trevi Therapeutics Inc) - Net earnings per one share growth for the current year|Earnings growth in current year PRAX|Anavex Life Sciences Corp - Earnings per share growth this year|CeriBell, Inc. - Net earnings per share growth this year|Expected net earnings per share growth this year prothena.com (PRTA)|Alector Therapeutics - Earnings growth in current year|ANNX: Earnings per share growth in current year|OMER: Earnings growth in current year|Neurogene Therapeutics - Earnings per share increase in current year|Net earnings per share growth this year ACIU|Earnings per share growth in current year VYGR|Earnings per share growth in current year Neumora Therapeutics, Inc. (NMRA)|Scilex Holding - Earnings per share growth this year|Earnings per share growth in current year Tevogen Bio Holdings, Inc. TVGN|ACOG: Earnings per share growth this year|Cognition Therapeutics, Inc. - Earnings growth in current year|Earnings per share growth rate in current year inhibikase.com|SAVA (Cassava Sciences) - Net earnings per share growth this year|Assertio (ASRT) - Earnings growth in current year|Earnings per share growth in current year Coya Therapeutics Inc|VTGN: Earnings per share increase in current year|Earnings per share growth in current year Ovid Therapeutics Inc. (OVID)|ABOS - Earnings per share growth rate in current year|Earnings growth in current year CRVO (CervoMed)|Alterity Therapeutics Ltd. - Earnings per share growth in current year|Clene Nanomedicine - Earnings growth in current year|Expected net earnings per share growth this year PepGen Inc. PEPG|Jupiter Neurosciences (JUNS) - Earnings per share growth in current year|Earnings per share growth rate in current year relmada.com (RLMD)|ANVS (Annovis Bio) - Earnings growth in current year|GRCE: Earnings per share increase in current year|Earnings growth in current year AIFF|Earnings growth in current year anewmeds.com (KLTO)|NeuroSense Therapeutics Ltd. - Net earnings per share growth this year|revivapharma.com - Earnings per share growth in current year|MetaVia, Inc. - Earnings growth in current year|Earnings per share growth rate in current year NeurAxis Inc.|heliusmedical.com (HSDT) - Earnings per share growth in current year|Earnings per share growth this year PASG|Net earnings per share growth this year NEUP|NERV: Earnings per share increase in current year|Earnings per share growth in current year Athira Pharma (ATHA)|Earnings per share growth in current year ADXN (Addex Therapeutics Ltd.)|Alzamend Neuro - Net earnings per share growth this year|Net earnings per one share growth for the current year CYCN (Cyclerion Therapeutics Inc.)|Protagenic - Earnings growth in current year|KTTA (Pasithea Therapeutics) - Earnings per share growth this year|CRGT (cortigent.com) - Net earnings per share growth this year|ATXI - Expected net earnings per share growth this year|BCLI (Brainstorm Cell Therapeutics, Inc.) - Earnings growth in current year|Earnings per share growth in current year CARA|Earnings growth in current year CHRO|ELYM (eliemtx.com) - Earnings per share increase in current year|Intra-Cellular Therapies, Inc. - Net earnings per share growth this year|Longboard Pharmaceuticals Inc - Earnings per share growth in current year|MRNS - Earnings per share growth in current year|NKGN (NKGen Biotech Corp) - Earnings per share growth this year|NeuroBo Pharmaceuticals (NRBO) - Earnings per share growth in current year|Earnings per share growth this year SAGE|SNPX (Synaptogenix) - Earnings growth in current year|Earnings per share growth rate in current year Trevena Inc. TRVN|Net earnings per share growth this year VIGL (Vigil Neuroscience)|Earnings growth in current year anewmeds.com (WENA)|Earnings per share growth in current year Cerevel Therapeutics CERE
